158 related articles for article (PubMed ID: 2306831)
1. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
3. Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle.
Huikuri HV; Yli-Mäyry S
Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2103-7. PubMed ID: 1279607
[TBL] [Abstract][Full Text] [Related]
4. The effect of rate on prolongation of ventricular refractoriness by quinidine in humans.
Rosenheck S; Sousa J; Calkins H; Kadish AH; Morady F
Pacing Clin Electrophysiol; 1990 Nov; 13(11 Pt 1):1379-84. PubMed ID: 1701891
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardia.
Morady F; Kou WH; Kadish AH; Nelson SD; Toivonen LK; Kushner JA; Schmaltz S; de Buitleir M
J Am Coll Cardiol; 1988 Aug; 12(2):388-94. PubMed ID: 3392332
[TBL] [Abstract][Full Text] [Related]
6. Electropharmacologic synergism with mexiletine and quinidine.
Duff HJ; Kolodgie FD; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1986; 8(4):840-6. PubMed ID: 2427827
[TBL] [Abstract][Full Text] [Related]
7. Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ.
Franz MR; Costard A
Circulation; 1988 May; 77(5):1177-84. PubMed ID: 3359594
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
[TBL] [Abstract][Full Text] [Related]
9. Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heart.
Bajaj AK; Kopelman HA; Wikswo JP; Cassidy F; Woosley RL; Roden DM
Circulation; 1987 May; 75(5):1065-73. PubMed ID: 2436827
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.
Ranger S; Talajic M; Lemery R; Roy D; Villemaire C; Nattel S
Circulation; 1991 Jun; 83(6):1987-94. PubMed ID: 2040051
[TBL] [Abstract][Full Text] [Related]
11. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
Costard-Jäckle A; Franz MR
J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
[TBL] [Abstract][Full Text] [Related]
12. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris.
Sedgwick ML; Rasmussen HS; Cobbe SM
Am J Cardiol; 1992 Dec; 70(18):1432-7. PubMed ID: 1442614
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic properties of a narrow isthmus in rabbit atrial tissue: cycle length dependent effect of quinidine.
Qi A; Kerr CR; Yeung-Lai-Wah JA
Can J Physiol Pharmacol; 1994 Apr; 72(4):375-81. PubMed ID: 7922869
[TBL] [Abstract][Full Text] [Related]
14. Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
Pastor A; Almendral JM; Arenal A; Lorca MT; Delcán JL
Am J Cardiol; 1993 Dec; 72(18):1389-94. PubMed ID: 8256732
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic effects of cibenzoline in humans related to dose and plasma concentration.
Touboul P; Atallah G; Kirkorian G; de Zuloaga C; Dufour A; Aymard MF; Lavaud P; Moleur P
Am Heart J; 1986 Aug; 112(2):333-9. PubMed ID: 3526853
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.
Bonavita GJ; Pires LA; Wagshal AB; Cuello C; Mittleman RS; Greene TO; Huang SK
Am Heart J; 1994 Apr; 127(4 Pt 1):847-51. PubMed ID: 8154423
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
Feld GK; Venkatesh N; Singh BN
Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
[TBL] [Abstract][Full Text] [Related]
18. Predicting ventricular tachycardia cycle length after procainamide by assessing cycle length-dependent changes in paced QRS duration.
Marchlinski FE; Buxton AE; Josephson ME; Schmitt C
Circulation; 1989 Jan; 79(1):39-46. PubMed ID: 2910546
[TBL] [Abstract][Full Text] [Related]
19. Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation.
Sager PT; Behboodikhah M
J Cardiovasc Electrophysiol; 1996 Feb; 7(2):102-12. PubMed ID: 8853020
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
